Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
(24 sites) United States
Stanford University School of Medicine, Stanford, California University of Miami, Miami, Florida Massachusetts General Hospital, Boston, Massachusetts Duke University Medical Center, Durham, North Carolina Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina The Ohio State University, Columbus, Ohio OU Health University of Oklahoma Medical Center, Oklahoma City, Oklahoma University of Texas Southwestern Medical Center, Dallas, Texas Austria
University Hospital Innsbruck, Innsbruck Vienna General Hospital AKH, Medical University of Vienna, Vienna Canada
Royal Columbian Hospital, New Westminster, British Columbia Kingston Health Sciences Centre, Kingston, Ontario Toronto General Hospital, Toronto, Ontario Montreal Heart Institute, Montreal, Quebec Czechia
Center of Cardiovascular and Transplant Surgery, Brno Institute for Clinical and Experimental Medicine, Prague France
CHU de Reims, Hôpital Robert Debré, Reims Lithuania
Hospital of Lithuanian university of Health sciences Kauno Klinikos, Kaunas Romania
Institute for Cardiovascular Diseases C.C. Iliescu, Bucharest Slovenia
University Medical Centre Ljubljana, Ljubljana United Kingdom
Royal Papworth Hospital, Cambridge University Hospital Coventry and Warwickshire, Coventry The James Cook University Hospital, Middlesbrough